nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anatomic Lung Resections Using Minimally Invasive Thoracic Surgery (MITS)
|
Quigley, Robert L. |
|
2000 |
1 |
3 |
p. 230-233 4 p. |
artikel |
2 |
Clinical Characteristics and the Impact of Surgery and Chemotherapy on Survival of Patients With Advanced and Metastatic Bronchioloalveolar Carcinoma: A Retrospective Study
|
Donker, Remco |
|
2000 |
1 |
3 |
p. 211-215 5 p. |
artikel |
3 |
Commentary on “Clinical Characteristics and the Impact of Surgery and Chemotherapy on Survival of Patients With Advanced and Metastatic Bronchioloalveolar Carcinoma: A Retrospective Study”
|
van Zandwijk, Nico |
|
2000 |
1 |
3 |
p. 216- 1 p. |
artikel |
4 |
Commentary on “Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer (NSCLC)”
|
Masters, Gregory A. |
|
2000 |
1 |
3 |
p. 208- 1 p. |
artikel |
5 |
Commentary on “Multimodality Treatment of Resectable Non–Small-Cell Lung Cancer”
|
Roth, Jack A. |
|
2000 |
1 |
3 |
p. 201- 1 p. |
artikel |
6 |
Commentary on “Small-Cell Lung Cancer at the Millennium: Radiotherapy Innovations”
|
Bonner, James A. |
|
2000 |
1 |
3 |
p. 191-193 3 p. |
artikel |
7 |
1999 European Cancer Conference Summary of Phase II Trials
|
|
|
2000 |
1 |
3 |
p. 175-176 2 p. |
artikel |
8 |
Gene Therapy for Lung Cancer
|
Mosca, Paul J. |
|
2000 |
1 |
3 |
p. 218-226 9 p. |
artikel |
9 |
Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer. A Southern Italy Cooperative Oncology Group Study
|
Comella, Pasquale |
|
2000 |
1 |
3 |
p. 202-207 6 p. |
artikel |
10 |
Letter to the Editor
|
Vallières, Eric |
|
2000 |
1 |
3 |
p. 234- 1 p. |
artikel |
11 |
Multimodality Treatment of Resectable Non–Small-Cell Lung Cancer
|
Ginsberg, Robert J. |
|
2000 |
1 |
3 |
p. 194-200 7 p. |
artikel |
12 |
Paclitaxel 175 mg/m2 plus Carboplatin versus Paclitaxel 225 mg/m2 plus Carboplatin for Advanced Non–Small-Cell Lung Cancer (NSCLC)
|
|
|
2000 |
1 |
3 |
p. 177-178 2 p. |
artikel |
13 |
Phase I Study of Recombinant Carcinoembryonic Antigen (CEA) Vaccinia Virus Vaccine With Post Vaccination Carcinoembryonic Antigen Peptide (CAP-1) Boost
|
Cole, David J. |
|
2000 |
1 |
3 |
p. 227-229 3 p. |
artikel |
14 |
Small-Cell Lung Cancer at the Millennium: Radiotherapy Innovations Improve Survival While New Chemotherapy Treatments Remain Unproven
|
Murray, Nevin |
|
2000 |
1 |
3 |
p. 181-190 10 p. |
artikel |